Calamos Wealth Management LLC Eli Lilly & CO Transaction History

Calamos Wealth Management LLC

$1.89 Billion
Q3 2024

A detailed history of Calamos Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Calamos Wealth Management LLC holds 27,965 shares of LLY stock, worth $21.5 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

27,965

Previous 31,772 11.98%

Holding current value

$21.5 Million

Previous $28.8 Million 13.87%

% of portfolio

1.31%

Previous 1.57%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $2.94 Million - $3.65 Million	-3,807 Reduced 11.98%	27,965 $24.8 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $426,223 - $534,515	588 Added 1.89%	31,772 $28.8 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $11,251 - $15,053	19 Added 0.06%	31,184 $24.3 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $124,995 - $147,352	-238 Reduced 0.76%	31,165 $18.2 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $4.3 Million - $5.92 Million	-9,881 Reduced 23.93%	31,403 $16.9 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $202,376 - $270,601	-577 Reduced 1.38%	41,284 $19.4 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $4.19 Million - $4.92 Million	-13,499 Reduced 24.38%	41,861 $14.4 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $101,288 - $118,021	315 Added 0.57%	55,360 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $478,222 - $544,984	1,613 Added 3.02%	55,045 $17.8 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $245,003 - $287,670	879 Added 1.67%	53,432 $17.3 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $1.81 Million - $2.25 Million	-7,710 Reduced 12.79%	52,553 $15.1 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $622,384 - $772,382	2,768 Added 4.81%	60,263 $16.6 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $3.74 Million - $4.6 Million	-16,871 Reduced 22.69%	57,495 $13.3 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $4.88 Million - $6.31 Million	27,013 Added 57.05%	74,366 $17.1 Million
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $1.71 Million - $2.21 Million	-10,395 Reduced 18.0%	47,353 $8.85 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $314,408 - $416,038	2,410 Added 4.36%	57,748 $9.75 Million
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $7.6 Million - $8.79 Million	51,963 Added 1539.64%	55,338 $8.19 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $248,830 - $299,464	1,824 Added 117.6%	3,375 $554,000
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $184,646 - $228,539	1,551 New	1,551 $215,000
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $215,930 - $241,906	-2,039 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $175,068 - $218,805	2,039 New	2,039 $219,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Eli Lilly & CO Transaction History